Cero Therapeutics (CERO) announced its board of directors has appointed Chris Ehrlich as CEO. Previously he held the position of interim CEO. In addition to his role at Cero, he currently serves as CEO of Launch One Acquisition Corporation (LPAA).
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CERO: